Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2

BACKGROUND: A novel coronavirus, SARS-CoV-2, which emerged at the end of 2019 and causes COVID-19, has resulted in worldwide human infections. While genetically distinct, SARS-CoV-1, the aetiological agent responsible for an outbreak of severe acute respiratory syndrome (SARS) in 2002–2003, utilises...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhiqiang, Monteil, Vanessa Marthe, Maurer-Stroh, Sebastian, Yew, Chow Wenn, Leong, Carol, Mohd-Ismail, Nur Khairiah, Cheyyatraivendran Arularasu, Suganya, Chow, Vincent Tak Kwong, Lin, Raymond Tzer Pin, Mirazimi, Ali, Hong, Wanjin, Tan, Yee-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376845/
https://www.ncbi.nlm.nih.gov/pubmed/32700671
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2000291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376845/
https://www.ncbi.nlm.nih.gov/pubmed/32700671
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2000291

Ejemplares similares